Hepatitis B

Heplisav-B Now Available for Hepatitis B Prevention in Adults

By January 08, 2018

Heplisav-B is the first and only two-dose vaccine for prevention of hepatitis B in adults.

Viread Generic Now Available From Teva

By December 19, 2017

Tenofovir disoproxil fumarate tablets are a nucleotide analog HIV-1 reverse transcriptase inhibitor.

ACP/CDC: Best Practice Advice for Hepatitis B Vaccination, Screening

November 21, 2017

All unvaccinated adults at risk for infection should be vaccinated; screening recommended for at-risk

New Vaccine for Hepatitis B Gets FDA Approval

By November 10, 2017

Two-dose vaccine for the prevention of hepatitis B in adults.

AAP: Hepatitis B Vaccine Should Be Given Within First 24 Hours of Life

August 29, 2017

Birth vaccine should be given for all medically stable infants weighing 2,000 g

EASL: 2017 HBV Infection Management Guidelines

By April 20, 2017

The updated guidelines include new definitions of disease phases, expanded indications for initiating treatment and recommendations for special populations.

Clinician Fails to Follow Up on Crucial Information

By March 02, 2017

This case examines a situation where a physician did not act on a bit of information that he should have taken quite seriously.

Tocilizumab-Related HBV Reactivation Examined in RA

February 13, 2017

Three patients with chronic HBV infection had reactivation, but they were asymptomatic

FDA Approves New Drug for Chronic HBV Infection

By November 11, 2016

The Food and Drug Administration (FDA) has approved Vemlidy (tenofovir alafenamide [TAF]) for the treatment of adults with hepatitis B virus (HBV) infection with compensated liver disease.